Rooting for Remdesivir; Pharmaceuticals & the Push for Progress
About this episode
Gilead’s experimental Covid-19 treatment caught the markets’ attention after STAT News reported encouraging early results in its phase 3 trial. Former FDA Commissioner Dr. Scott Gottlieb explains the antiviral Remdesivir and explains its potential role in flattening the pandemic’s curve. French pharmaceutical company Sanofi has partnered with peer GlaxoSmithKline to develop a Covid-19 vaccine in the next 18 months. Sanofi has also partnered with a startup to create a coronavirus test using a smartphone. CEO Paul Hudson explains the news, the technology, and the path ahead for a healthier planet.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Squawk Pod publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Squawk Pod
25 Years Later 9/11/26
Squawk Pod
AI Alarms, Canada’s Opposition, The GOP Convention 9/10/26
Squawk Pod
Microsoft’s Brad Smith & Utah Gov. Cox: AI, Teaching, & Peace 9/9/26
Squawk Pod
GLPs & Fraud with Dr. Oz & Kevin O’Leary’s $11m Baseball Card 9/8/26
Squawk Pod